TNF and irritable bowel syndrome: Noteworthy, an increased expression of GRP78 and members of UPR, which activate the pro-inflammatory cytokine TNF-α [35,36] that is directly implicated in the pathogenesis of IBD, can be reversed by RCME proposing this mixture to be considered in IBD therapies.